EGFR was reported to be overexpressed in anaplastic thyroid carcinomas, follicular thyroid carcinomas and in primary medullary carcinomas, with no evidence of somatic EGFR mutations (31–34). Here, EGFR is linked to medullary thyroid gland carcinoma.